Tevogen Bio Holdings (TVGN) Income Statement: Revenue & Earnings

Tevogen Bio Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tevogen Bio Holdings Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00
Cost of Revenue	0.40	0.00	0.00	0.00
Gross Profit	-0.40	0.00	0.00	0.00
Operating Expenses
Research & Development	31.03	4.40	5.77	2.96
Selling, General & Administrative	22.13	4.44	0.95	1.66
Operating Expenses	53.16	8.84	0.95	4.62
Operating Income	-53.56	-8.84	-0.95	-4.62
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00
Interest Expense	0.18	1.21	-0.93	0.60
Other Income/Expense	39.84	-50.43	5.36	-10.38
Income
Income Before Tax	-13.73	-60.48	4.41	-15.60
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-10.11	-60.48	4.41	-15.60
Net Income - Continuous Operations	-10.11	-60.48	4.41	-15.60
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-13.14	-58.89	4.41	-14.99
EBIT	-13.54	-59.27	4.41	-15.00
Depreciation & Amortization	0.40	0.38	0.23	0.01
Earnings Per Share
Basic EPS	-	-	-	-
Diluted EPS	-	-	-	-
Basic Shares Outstanding	146.67	165.42	120.00	120.00
Diluted Shares Outstanding	146.67	165.42	120.00	120.00